Due to the critical role of PPAR-γ in macrophage M2 polarization, the pharmacological activation of PPAR-γ with TZDs focusing on regulation of macrophages polarization might be a new target in the NAFLD treatment. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.